Clinical Trial News and Research

RSS

Daily orforglipron treatment reduces weight and blood sugar in seniors

A new analysis to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) examined daily oral orforglipron treatment for the treatment of obesity, with or without diabetes, in users aged 65 years and over, with results and a safety profile similar to that seen in the ATTAIN clinical trial programme population.

11 May 2026

Could a fingerprick at home flag your Alzheimer's risk? New study says yes

Researchers demonstrated that self-administered fingerprick blood tests measuring p-tau217 and GFAP, returned by post, correlate strongly with venous blood biomarkers and cognitive performance across the Alzheimer's disease continuum. Combined with computerized cognitive testing, this at-home approach offers a scalable, patient-friendly tool for triaging individuals at risk of AD-related impairment.

10 May 2026

Autistic people gain measurable police-interaction skills after short VR training

A randomized controlled trial found that Floreo’s virtual reality Police Safety Module helped autistic teens and adults reduce fidgeting during live police-interaction assessments compared with video-based BeSAFE training. Both groups reported greater knowledge and comfort after training, but the clearest behavioral gains were seen in the VR group, supporting immersive practice as a promising tool for safer police encounters.

10 May 2026

Asthma medication formoterol shows promise for treating fatty liver disease

MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide.

8 May 2026

A brain-based approach may improve smoking cessation treatment success

For many people who smoke, quitting is not just a matter of willpower. It is a tug-of-war in the brain – between the pull of reward and the ability to resist.

8 May 2026

AI-driven hormone tracking could help detect infertility early and improve conception

Men and women who appear hormonally 'normal' may still have undetected disruptions in the timing and coordination of their reproductive hormones that could impair fertility, according to research presented at the 28th European Congress of Endocrinology in Prague.

8 May 2026

Clinicians find evolutionary explanations for anxiety more helpful than genetics

Mental health clinicians are over five times more likely to see evolutionary explanations of anxiety as helpful for their patients, rather than the genetic approaches currently taught to trainee doctors and psychiatrists in the UK and US, a new study shows.

8 May 2026

The power of organoids in speeding up lifesaving drug development

Organoids are miniature tissue or organ models formed by stem cells (including pluripotent stem cells, tissue-specific adult stem cells, etc.) or progenitor cells in an in vitro three-dimensional culture system, which possess structural features and partial functions analogous to their corresponding in vivo organs. In 2009, the Hans Clevers laboratory developed the first intestinal organoid, marking the inception of organoid-based disease modeling.

8 May 2026

Diverse leukemia stem cells may drive AML relapse after therapy

Scientists from the German Cancer Research Center (DKFZ) and the HI-STEM* Stem Cell Institute have deciphered a key mechanism that contributes to treatment failure in acute myeloid leukemia (AML).

7 May 2026

Heart disease risk prediction tool proves effective across global populations

A tool developed by the American Heart Association (AHA), proven to accurately predict heart disease risk for Americans, can be applied to the global population, a new study led by NYU Langone Health shows.

7 May 2026

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Menopause symptoms like hot flushes can be debilitating. Dr. Katie Barber highlights new treatments, including fezolinetant, for improved patient care.

7 May 2026

A new combined therapy to boost the immune system against cancer

Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective.

7 May 2026

Smokers now view e-cigarettes as riskier after lung injury crisis

The study analyzes changing views on e-cigarette risks, noting EVALI's role in shaping public perception and its implications for smoking cessation.

7 May 2026

Targeted RAS inhibitor shows promise against pancreatic cancer mutations

The targeted RAS inhibitor therapy daraxonrasib demonstrated the potential to improve patient outcomes over current standard treatments for patients with RAS-mutant pancreatic cancer, according to results of a Phase 1/2 trial led by researchers at The University of Texas MD Anderson Cancer Center.

7 May 2026

Daily peanut exposure shows success in treating toddler allergies

Researchers at Karolinska Institutet have successfully treated children aged 1–3 years with peanut allergies. The children slowly became accustomed to eating peanuts by consuming small amounts of them daily, which were gradually increased over time.

6 May 2026

First European trial tests CAR T therapy in amyloidosis patients

Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, led by UCL and UCLH researchers.

6 May 2026

GLP-1 weight-loss drugs modulate brain reward circuits to suppress eating for pleasure

A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain.

6 May 2026

Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage

Calla Lily Clinical Care, a women’s health-focused medical technology company, today announced dosing of the first patients in the FREEDOM clinical trial.

6 May 2026

App launched to track heart health after high-risk pregnancies

The MumCare app addresses postpartum cardiovascular risk, supporting women in managing health after pregnancy complications through personalized digital tools.

6 May 2026

Virtual reality training improves police interactions for autistic individuals

A new study led by researchers at Children's Hospital of Philadelphia and St. Joseph's University found that an innovative virtual reality intervention was helpful for improving interactions between autistic teens and adults and law enforcement officers.

5 May 2026